BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 08, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ONO-4538: Phase II started

Ono disclosed in its fiscal 1Q11 earnings ending June 30 that partner Bristol-Myers began a double-blind, North American Phase II trial to evaluate 0.3, 2 and 10 mg/kg IV BMS-936558 every 3...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >